Roche Holding AG 2011 AR2
The report highlights Roche's progress in 2011, focusing on its Personalised Healthcare strategy and the successful launch of targeted medicines and companion diagnostics. Financially, the Roche Group recorded sales of 42.5 billion Swiss francs and invested 8.1 billion Swiss francs in research and development. In sustainability, Roche was named the Healthcare Super-sector Leader in the Dow Jones Sustainability Indexes for the third consecutive year. The company also improved its eco-balance impact per employee by 4% and reduced energy consumption by 7.7%, remaining on track to meet its long-term environmental goals.
Company: Roche Holding AG
Sector: Manufacturing
Country: Switzerland
Year: 2011
Type: AR2
Pages: 146
Back to company
Roche Holding AG
Annual Report
The report highlights Roche's progress in 2011, focusing on its Personalised Healthcare strategy and the successful launch of targeted medicines and companion diagnostics. Financially, the Roche Group recorded sales of 42.5 billion Swiss francs and invested 8.1 billion Swiss francs in research and development. In sustainability, Roche was named the Healthcare Super-sector Leader in the Dow Jones Sustainability Indexes for the third consecutive year. The company also improved its eco-balance impact per employee by 4% and reduced energy consumption by 7.7%, remaining on track to meet its long-term environmental goals.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2011
Reporting Period
Jan 1, 2011 - Dec 31, 2011
Fiscal Year
2011
Published
Jan 27, 2012
Type
Annual Report with Sustainability Disclosures
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Assurance
Assurance Provider
Assurance Standard
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Energy Consumption
Water Consumption
Women in Management
Workplace Fatalities
Employees